acetylleucyl-leucyl-norleucinal has been researched along with ebselen in 4 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (ebselen) | Trials (ebselen) | Recent Studies (post-2010) (ebselen) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 839 | 9 | 366 |
| Protein | Taxonomy | acetylleucyl-leucyl-norleucinal (IC50) | ebselen (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 11.6872 | |
| Arrestin, beta 1 | Homo sapiens (human) | 1.524 | |
| MPI protein | Homo sapiens (human) | 0.19 | |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 15.0867 | |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 5.29 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 0.88 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 0.9009 | |
| Spike glycoprotein | Betacoronavirus England 1 | 0.67 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.67 | |
| neutrophil cytosol factor 1 | Homo sapiens (human) | 0.39 | |
| phosphomannomutase 2 | Homo sapiens (human) | 0.672 | |
| perilipin-5 | Homo sapiens (human) | 1.101 | |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | 13.2 | |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | 0.111 | |
| perilipin-1 | Homo sapiens (human) | 3.41 | |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | 1.15 | |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | 1.15 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 2.2555 | |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | 5.4 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.67 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 2.1 | |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | 0.742 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Procathepsin L | Homo sapiens (human) | 0.67 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.67 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.67 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.62 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.7928 | |
| Macrophage migration inhibitory factor | Homo sapiens (human) | 2.4 | |
| Insulin-degrading enzyme | Homo sapiens (human) | 0.028 | |
| Urease subunit alpha | Helicobacter pylori 26695 | 3.745 | |
| Toxin B | Clostridioides difficile | 0.0172 | |
| Caspase-1 | Homo sapiens (human) | 4.04 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.7575 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 2.43 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.67 | |
| Urease subunit beta | Helicobacter pylori 26695 | 3.745 | |
| UDP-glucose 4-epimerase | Homo sapiens (human) | 0.014 | |
| Structural capsid protein | Human immunodeficiency virus 1 | 0.0467 | |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 0.4 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.67 | |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | 0.73 | |
| Histone deacetylase 6 | Homo sapiens (human) | 4.05 | |
| Histone deacetylase 9 | Homo sapiens (human) | 3.7 | |
| Histone deacetylase 5 | Homo sapiens (human) | 3.4 | |
| large T antigen | Betapolyomavirus macacae | 13.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, SA; Banerjee, S; Gayen, S; Ghosh, K; Jha, T | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Basier, C; Beale, R; Bineva-Todd, G; Canal, B; Curran, JF; Deegan, T; Diffley, JFX; Fujisawa, R; Howell, M; Joshi, D; Labib, K; Lim, CT; Milligan, JC; Nagaraj, H; O'Reilly, N; Papageorgiou, G; Soudy, C; Tan, KW; Ulferts, R; Weissmann, F; Wu, M; Zeisner, TU | 1 |
1 review(s) available for acetylleucyl-leucyl-norleucinal and ebselen
| Article | Year |
|---|---|
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
Topics: Antiviral Agents; Catalytic Domain; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Molecular Docking Simulation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2021 |
3 other study(ies) available for acetylleucyl-leucyl-norleucinal and ebselen
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antiviral Agents; Azoles; Chlorocebus aethiops; Coronavirus 3C Proteases; Drug Evaluation, Preclinical; Enzyme Assays; Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; Isoindoles; Leupeptins; Organoselenium Compounds; Peptidomimetics; Reproducibility of Results; RNA-Binding Proteins; SARS-CoV-2; Small Molecule Libraries; Vero Cells; Viral Nonstructural Proteins | 2021 |